These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2281391)
1. [The effect of plasmapheresis on hemostasis in lung cancer patients]. Tarabykin AA; Kliachkin BM; Basargin ST Ter Arkh; 1990; 62(9):108-11. PubMed ID: 2281391 [TBL] [Abstract][Full Text] [Related]
2. [Plasmapheresis in combined measures to prevent postoperative thromboembolic complications in cancer patients]. Tarabykin AA; Kliachkin BM; Basargin ST Anesteziol Reanimatol; 1990; (1):55-7. PubMed ID: 2350050 [TBL] [Abstract][Full Text] [Related]
3. [The prevention of the hypercoagulation syndrome during the combined treatment of lung cancer patients using artificial hyperglycemia]. Fradkin SZ; Zhavrid EA; Prokhorova VI; Nodel'son SE; Khodina TV; Antipova LI; Demidchik IuE Vopr Onkol; 1991; 37(3):321-9. PubMed ID: 2031327 [TBL] [Abstract][Full Text] [Related]
4. [The hemostatic system during and after surgery in lung cancer patients and its role in the development of postoperative complications]. Madzhuga AV Anesteziol Reanimatol; 1988; (5):69-71. PubMed ID: 3218787 [No Abstract] [Full Text] [Related]
5. [Plasmapheresis in the combined therapy of the acute rejection reaction and of suppurative-septic complications in the pretransplantation period]. Lopatkin NA; Kozlov VA; Iarmolinskiĭ IS; Danilov AP; Khalatov AS Urol Nefrol (Mosk); 1989; (4):3-7. PubMed ID: 2800073 [TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies. Patel A; Anraku M; Darling GE; Shepherd FA; Pierre AF; Waddell TK; Keshavjee S; de Perrot M J Thorac Cardiovasc Surg; 2009 Oct; 138(4):843-8. PubMed ID: 19660355 [TBL] [Abstract][Full Text] [Related]
8. [Effect of dipyridamole on changes produced by halothane in blood hemostasis]. de la Cruz Cortés JP; Aguilar Muñoz A; Martos Crespo F; Rubio Santiago M; Sánchez de la Cuesta F Sangre (Barc); 1985; 30(4-A):387-96. PubMed ID: 4071353 [No Abstract] [Full Text] [Related]
9. [Use of plasmapheresis in multimodality correction of hemostasis disorders in patients with calculous pyelonephritis]. Nemark AI; Mazyrko AV; Astakhov IuI Ter Arkh; 1989; 61(6):86-8. PubMed ID: 2799724 [TBL] [Abstract][Full Text] [Related]
10. [Changes in the system of hemostasis in the pre- and postoperative period]. Kuzin MI; Dreizina AM; Dobrovol'skiĭ VI; Shumbalina LF; Smolianitskiĭ Khirurgiia (Mosk); 1974 Nov; 0(11):64-73. PubMed ID: 4431188 [No Abstract] [Full Text] [Related]
11. [Preoperative detection of the postoperative risk of thromboembolism. Results of a prospective study. I. Concept and protocol of the study]. Vogel G; Liedloff H; Heerdegen R; Huyke R Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):497-9. PubMed ID: 6083917 [No Abstract] [Full Text] [Related]
12. [The optimization of the heparin prophylaxis of postoperative thromboembolic complications]. Nozdrachev IuI Vestn Khir Im I I Grek; 1995; 154(2):61-5. PubMed ID: 8540191 [TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of special methods for preventing postoperative venous thromboembolic complications in elderly oncological patients]. Nodel'son SE Anesteziol Reanimatol; 1985; (2):55-8. PubMed ID: 4003841 [No Abstract] [Full Text] [Related]
14. [Up-to-date technologies in preoperative preparation and postoperative period in patients with progressive destructive pulmonary tuberculosis]. Karpina NL; Lepekha LN; Zhillin IuN; Erokhin VV Probl Tuberk Bolezn Legk; 2008; (9):25-8. PubMed ID: 19062568 [TBL] [Abstract][Full Text] [Related]
15. [Use of non-medicamentous methods of treatment with the aim to improve the immune status of patients with suppurative diseases and malignant neoformations of the lungs]. Kogosova LS; Kogosov IuA; Kalabukha IA; Konovalov EP Probl Tuberk; 1993; (3):37-9. PubMed ID: 7984589 [TBL] [Abstract][Full Text] [Related]
16. [Complex prevention of thrombotic complications in patients with colorectal cancer during different stages of surgical treatment]. Mal'kov OA; Dolgikh VT; Lukach VN Anesteziol Reanimatol; 2001; (5):52-4. PubMed ID: 11757303 [TBL] [Abstract][Full Text] [Related]
17. [Detection of fibrinolytic split products in patient collections with disordered hemostasis. I. In pathologically verified lung cancer. II. In thrombotic/embolic occurrences]. Bube FW; Egenolf F Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):447-54. PubMed ID: 6169607 [TBL] [Abstract][Full Text] [Related]